Case Studies

Strategy Workshop

The Challenge: TherapeutAix was contacted by an institution wanting to define areas to build capabilities. Their goal was to better complement expertise and to meet

Read More »

Advancing Assets

The Challenge: TherapeutAix was approached by a small biotech company that operated in a fully virtual setting. To progress assets on a novel drug delivery

Read More »

Asset for Fibrotic Disease

The Challenge: TherapeutAix was approached by a US-based biotech company to review an asset that they were considering repositioning for fibrotic disease. The company asked for

Read More »

Target and Asset Review

The Challenge: TherapeutAix was approached by a small virtual biotech to review a target and asset that for a rare fibrotic disease. The company asked for specific help in reviewing the target, existing data,

Read More »

Translational Strategy

The Challenge: A small, highly virtualized biotech had identified an attractive target in fibrotic diseases and needed a translational strategy to generate clinical data that

Read More »

Contact us

Get in touch with the team today to find out how we can guide you to help bring your molecules with promise to life efficiently and in the most cost-effective way. 

We offer an initial review of your project completely free of charge. 

We’d like to send you our company updates, invites to events and any other relevant news. By providing your details and subscribing to this list, you are giving us your consent to send you these updates.

We’ll always be mindful of how often we send our updates and you can amend your preferences at any time.

We’ll never sell or swap your data with any organisation and we’ll store your details securely, respecting your trust and privacy. Please view our privacy policy for further details.

Marketing Permissions
Please select all the ways you would like to hear from TherapeutAix:
You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.